Target intelligence / Profile preview

Multiple C2 domains, transmembrane 21 pseudogene

Molecular classification: Other (Pseudogene)

Overview

ENSG00000287328 encodes a "pseudogene" associated with the multiple C2 domains, transmembrane 21 (MCTP2), and does not produce a functional protein product[4]. Pseudogenes are segments of DNA that are similar to functional genes but contain defects (such as insertions, deletions, or premature stop codons) that prevent them from expressing a functional protein[4]. This pseudogene is not considered a therapeutic target and lacks the molecular functionality, biological roles, or disease associations typical of genuine protein targets. No drugs, mechanisms of action, biomarker roles, or safety concerns are described for this pseudogene.

Other names: MCTP2 pseudogeneMultiple C2 domains, transmembrane 21 (MCTP2) pseudogeneGC15P096577

Beyond the preview

Go deeper on Multiple C2 domains, transmembrane 21 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple C2 domains, transmembrane 21 pseudogene.

Explore the full profile